FMC Corp vs Vanguard Total International Stock Index Fund ETF — how do they compare? FMC Corp trades at $11.24 (market cap $1.36B), while Vanguard Total International Stock Index Fund ETF trades at $84.21. The key difference: FMC Corp pays a 2.95% dividend while Vanguard Total International Stock Index Fund ETF pays none, and Vanguard Total International Stock Index Fund ETF is trading nearer its 52-week high, FMC Corp nearer its low. Which is the better fit depends on your goals.
| FMC | VXUS | |
|---|---|---|
Market Cap | $1.36B | — |
Sector | Basic Materials | Sector/Thematic |
52-Week High | $43.90 | $87.06 |
52-Week Low | $10.72 | $68.24 |
Enterprise Value | $5.50B | — |
Dividend Yield | 2.95% | — |
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
VXUS trades at $83.96, down 0.83% on the day, with a bullish technical signal driven by moving averages. The ETF provides broad international stock exposure across developed and emerging markets, with over 8,700 holdings. Recent news highlights its role in diversification and cost efficiency compared to peers.
The outlook for VXUS hinges on global equity performance relative to the US, with potential upside from valuation discounts. Risks include persistent inflation and growth concerns outside the US. Analyst sentiment is mixed, with some caution due to macroeconomic headwinds affecting international markets.
Trailing returns across standard periods
Latest headlines on both assets
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →VXUS is a comprehensive, low-cost ETF that tracks the FTSE Global All Cap ex US Index, providing exposure to over 8,500 stocks in both developed and emerging markets outside the United States. It serves as a foundational building block for international diversification, allowing investors to own a market-cap-weighted slice of the entire non-U.S. investable equity universe in a single vehicle.
Read more on VXUS →